Table 3.

SUV and TATV results of lymph nodes and distant metastases

Patient	Localization	Dimension^a [mm]	SUVmax [g/mL]		SUVmean [g/mL]		SUV42%/SUVbackground [1]		Tracer avid tumor volume [cm³]
			FDG	RGD	FDG	RGD	FDG	RGD	FDG	RGD
1	Left IIb	10	3	3.2	1.9	2	3.3	4.5	3.7	5
2	Left IIa	9	4.7	1.3	2.6	0.8	4.3	2.2	3.5	4.4
3	Left IIa–IIb	4	15	3.1	8.4	1.8	16.6	3.9	8.5	14
4	None	–	–	–	–		–	–	–	–
5	Right IIa	10	11.2	2.8	6.7	1.8	14	3.5	1	5.4
	Right IIa	9	13	4.8	9	2.9	16.2	6	3.2	7.5
	Right IIa	6	3.9	3.5	2.3	2.1	4.9	4.4	2.4	5
6	Left IIa	8	7.7	3.5	4.5	2	8.5	4.4	1.3	2.5
	Right III	15	6	2.2	3.6	1.2	6.7	2.8	1.4	4.7
	Left III	9	5.2	2.5	3	1.4	5.8	3.1	1.6	4.1
	Right IV	7	6	1.9	3.7	1.1	6.7	2.4	1.5	5.2
	Left IV	7	7.8	1.9	4.6	1.2	8.7	2.4	1.1	4.5
	Right V	7.5	7.4	1.7	4.8	1	8.2	2.1	1	4.5
7	Right IIa	9	4	1.9	2.2	1.1	4.4	2.4	3	5
	Left IIb	5	2.3	2.4	1.3	1.3	2.5	3	3.2	4.6
8	Right IIa	14	4	1.2	2.5	0.9	4.4	1.5	4	7
	Right IIb	13	7	2.4	4.1	1.4	7.8	3	3.6	6
9	Left I	17	4	1.3	2.1	1	4.4	1.6	5.7	8.2
	Left IIa	17	4.5	1.4	2.4	1	5	1.7	6	9
	Left IIb	12	4	1.4	2.1	0.9	4.4	1.7	4.5	5.9
	Left III	13	5	2.2	3	1.2	5.5	2.7	4	6.5
10	Left retropharyngeal	7	7	1.4	4.1	1	7.8	1.7	5.6	8
	Right retropharyngeal	5	4	1	2	0.8	4.4	1.2	3	5.3
	Right IIa	7	7	1.5	4	1.3	7.8	1.9	5	7.7
Mean		8.5	7	2.5	3.5	1.3	6.8	2.8	3.2	6.1
SD		2.7	4.1	1.2	2.6	0.7	5	1.5	2.1	5.7
p				0.0017		0.0017		0.0017		0.0017
5	Pulmonary right upper lobe	16	12	2.3	7.7	1.4	15	2.9	0.9	2
	Pulmonary left upper lobe	10	11.8	1.2	7.7	0.7	14.8	1.5	0.7	3.6
Mean			11.9	1.7	7.7	0.8	14.9	2.2	0.8	2.8

^aLymph node measure: small axis